191 related articles for article (PubMed ID: 19777373)
21. A vision 'bolt-on' increases the responsiveness of EQ-5D: preliminary evidence from a study of cataract surgery.
Gandhi M; Ang M; Teo K; Wong CW; Wei YC; Tan RL; Janssen MF; Luo N
Eur J Health Econ; 2020 Jun; 21(4):501-511. PubMed ID: 31902023
[TBL] [Abstract][Full Text] [Related]
22. Scale characteristics and mapping accuracy of the US EQ-5D, UK EQ-5D, and SF-6D in patients with rheumatoid arthritis.
Wolfe F; Michaud K; Wallenstein G
J Rheumatol; 2010 Aug; 37(8):1615-25. PubMed ID: 20551106
[TBL] [Abstract][Full Text] [Related]
23. Using the health assessment questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis.
Bansback N; Marra C; Tsuchiya A; Anis A; Guh D; Hammond T; Brazier J
Arthritis Rheum; 2007 Aug; 57(6):963-71. PubMed ID: 17665482
[TBL] [Abstract][Full Text] [Related]
24. A comparison between the EQ-5D and the SF-6D in patients with chronic obstructive pulmonary disease (COPD).
Chen J; Wong CK; McGhee SM; Pang PK; Yu WC
PLoS One; 2014; 9(11):e112389. PubMed ID: 25379673
[TBL] [Abstract][Full Text] [Related]
25. Validating and assessing the sensitivity of the Health Assessment Questionnaire-Disability Index-derived Short Form-6D in patients with early aggressive rheumatoid arthritis.
Amjadi SS; Maranian PM; Paulus HE; Kaplan RM; Ranganath VK; Furst DE; Khanna PP; Khanna D;
J Rheumatol; 2009 Jun; 36(6):1150-7. PubMed ID: 19369459
[TBL] [Abstract][Full Text] [Related]
26. Discriminative validity of the EQ-5D-5 L and SF-12 in older adults with arthritis.
Tawiah AK; Al Sayah F; Ohinmaa A; Johnson JA
Health Qual Life Outcomes; 2019 Apr; 17(1):68. PubMed ID: 30995930
[TBL] [Abstract][Full Text] [Related]
27. The impact of a revised EQ-5D population scoring on preference-based utility scores in an inflammatory arthritis cohort.
Adams R; Craig BM; Walsh CD; Veale DJ; Bresnihan B; FitzGerald O; Barry M
Value Health; 2011; 14(6):921-7. PubMed ID: 21914514
[TBL] [Abstract][Full Text] [Related]
28. Comparative performance of the EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes.
Sayah FA; Qiu W; Xie F; Johnson JA
Qual Life Res; 2017 Aug; 26(8):2057-2066. PubMed ID: 28364183
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D.
Walters SJ; Brazier JE
Qual Life Res; 2005 Aug; 14(6):1523-32. PubMed ID: 16110932
[TBL] [Abstract][Full Text] [Related]
30. Evaluating a falls prevention intervention in older home care recipients: a comparison of SF-6D and EQ-5D.
Bjerk M; Brovold T; Davis JC; Bergland A
Qual Life Res; 2019 Dec; 28(12):3187-3195. PubMed ID: 31364036
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohort.
Gaujoux-Viala C; Rat AC; Guillemin F; Flipo RM; Fardellone P; Bourgeois P; Fautrel B
J Rheumatol; 2011 Aug; 38(8):1576-84. PubMed ID: 21532054
[TBL] [Abstract][Full Text] [Related]
32. The responsiveness of quality of life utilities to change in depression: a comparison of instruments (SF-6D, EQ-5D, and DFD).
Gerhards SA; Huibers MJ; Theunissen KA; de Graaf LE; Widdershoven GA; Evers SM
Value Health; 2011; 14(5):732-9. PubMed ID: 21839412
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease.
van Stel HF; Buskens E
Health Qual Life Outcomes; 2006 Mar; 4():20. PubMed ID: 16563170
[TBL] [Abstract][Full Text] [Related]
34. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
Wong CKH; Lang BHH; Yu HMS; Lam CLK
Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD).
Yang F; Lau T; Lee E; Vathsala A; Chia KS; Luo N
Eur J Health Econ; 2015 Dec; 16(9):1019-26. PubMed ID: 25519850
[TBL] [Abstract][Full Text] [Related]
36. Comparison of EQ-5D and SF-6D utilities in mental health patients.
Lamers LM; Bouwmans CA; van Straten A; Donker MC; Hakkaart L
Health Econ; 2006 Nov; 15(11):1229-36. PubMed ID: 16625671
[TBL] [Abstract][Full Text] [Related]
37. Are indirect utility measures reliable and responsive in rheumatoid arthritis patients?
Marra CA; Rashidi AA; Guh D; Kopec JA; Abrahamowicz M; Esdaile JM; Brazier JE; Fortin PR; Anis AH
Qual Life Res; 2005 Jun; 14(5):1333-44. PubMed ID: 16047508
[TBL] [Abstract][Full Text] [Related]
38. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus.
Aggarwal R; Wilke CT; Pickard AS; Vats V; Mikolaitis R; Fogg L; Block JA; Jolly M
J Rheumatol; 2009 Jun; 36(6):1209-16. PubMed ID: 19369452
[TBL] [Abstract][Full Text] [Related]
39. The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D.
Sach TH; Barton GR; Doherty M; Muir KR; Jenkinson C; Avery AJ
Int J Obes (Lond); 2007 Jan; 31(1):189-96. PubMed ID: 16682976
[TBL] [Abstract][Full Text] [Related]
40. Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis.
Thaweethamcharoen T; Noparatayaporn P; Sritippayawan S; Aiyasanon N
Value Health Reg Issues; 2019 May; 18():59-64. PubMed ID: 30502661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
